178 related articles for article (PubMed ID: 12467137)
1. Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.
RodrÃguez-Burford C; Steele VE; Anderson AS; Stockard CR; Weiss HL; Eto I; Johanning GL; Grizzle WE; Grubbs CJ
Nutr Cancer; 2002; 43(1):67-75. PubMed ID: 12467137
[TBL] [Abstract][Full Text] [Related]
2. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
RodrÃguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
[TBL] [Abstract][Full Text] [Related]
3. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
4. Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.
Swanson SM; Whitaker LM; Stockard CR; Myers RB; Oelschlager D; Grizzle WE; Juliana MM; Grubbs CJ
Anticancer Res; 1997; 17(6D):4639-45. PubMed ID: 9494582
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
6. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the protective effects of 17beta-estradiol, biochanin A and bisphenol A on mammary gland differentiation and tumorigenesis in rats.
Yin H; Ito A; Bhattacharjee D; Hoshi M
Indian J Exp Biol; 2006 Jul; 44(7):540-6. PubMed ID: 16872042
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone.
Grubbs CJ; Farnell DR; Hill DL; McDonough KC
J Natl Cancer Inst; 1985 Apr; 74(4):927-31. PubMed ID: 3857386
[TBL] [Abstract][Full Text] [Related]
9. Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis.
Cohen LA; Epstein M; Saa-Pabon V; Meschter C; Zang E
Nutr Cancer; 1994; 21(3):271-83. PubMed ID: 8072880
[TBL] [Abstract][Full Text] [Related]
10. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
11. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
12. Prepubertal zearalenone exposure suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis but causes severe endocrine disruption in female Sprague-Dawley rats.
Nikaido Y; Yoshizawa K; Pei RJ; Yuri T; Danbara N; Hatano T; Tsubura A
Nutr Cancer; 2003; 47(2):164-70. PubMed ID: 15087269
[TBL] [Abstract][Full Text] [Related]
13. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
Green A; Shilkaitis A; Christov K
Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
[TBL] [Abstract][Full Text] [Related]
14. Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland.
McCormick DL; Rao KV; Johnson WD; Bowman-Gram TA; Steele VE; Lubet RA; Kellof GJ
Cancer Res; 1996 Apr; 56(8):1724-6. PubMed ID: 8620482
[TBL] [Abstract][Full Text] [Related]
15. Tumor-protective and tumor-promoting actions of dietary whey proteins in an N-methyl-N-nitrosourea model of rat mammary carcinogenesis.
Eason RR; Till SR; Frank JA; Badger TM; Korourian S; Simmen FA; Simmen RC
Nutr Cancer; 2006; 55(2):171-7. PubMed ID: 17044772
[TBL] [Abstract][Full Text] [Related]
16. Dietary lignin, and insoluble fiber, enhance uterine cancer but did not influence mammary cancer induced by N-methyl-N-nitrosourea in rats.
Birt DF; Markin RS; Blackwood D; Harvell DM; Shull JD; Pennington KL
Nutr Cancer; 1998; 31(1):24-30. PubMed ID: 9682245
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.
Lubet RA; Christov K; Nunez NP; Hursting SD; Steele VE; Juliana MM; Eto I; Grubbs CJ
Carcinogenesis; 2005 Feb; 26(2):441-8. PubMed ID: 15591091
[TBL] [Abstract][Full Text] [Related]
19. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
20. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]